Results 251 to 260 of about 1,793,619 (305)
Some of the next articles are maybe not open access.

Related searches:

Cardiac dysfunction in cirrhosis

Best Practice & Research Clinical Gastroenterology, 2007
Cirrhosis is known to be associated with numerous cardiovascular abnormalities. These include increased cardiac output and decreased arterial pressure and total peripheral resistance. Despite this increased baseline cardiac output, patients with cirrhosis show an attenuated systolic and diastolic function in the face of pharmacological, physiological ...
Ralph F, Lee   +2 more
openaire   +2 more sources

Sarcopenia and Cardiac Dysfunction

Cardiology in Review, 2019
Although muscle loss is part of the natural course of human aging, sarcopenia has been associated with an increased risk of physical disability and mortality in older patients. Many heart failure patients concomitantly develop deficits in muscle mass and strength, resulting in decreased quality of life and exercise capacity.
Alexandra, Wong, William, Frishman
openaire   +2 more sources

Cardiac dysfunction in cirrhosis

Hepatology Research, 2003
In cirrhosis, cardiac symptoms and physical signs occur as the liver functions worsen. Cirrhosis is associated with hyperdynamic circulation and beta-adrenergic system activation responsible for the cardiovascular changes. The purpose of the present study was to explore the cardiovascular response to exercise in cirrhotic patients.
Duran, Kaya   +4 more
openaire   +2 more sources

Cardiac Function and Dysfunction in Sepsis

Clinics in Chest Medicine, 2016
Cardiac function and dysfunction are important in the clinical outcomes of sepsis and septic shock. Cardiac dysfunction is not a single entity, but is a broad spectrum of syndromes that result in biventricular cardiac dysfunction manifested by both systolic and diastolic dysfunction and is influenced by cardiac loading conditions (ie, preload and ...
Margaret M Parker, Kimberly E Fenton
exaly   +3 more sources

Trastuzumab-Related Cardiac Dysfunction

Journal of the National Comprehensive Cancer Network, 2011
The use of trastuzumab in the adjuvant and metastatic treatment of breast cancer is associated with both symptomatic and asymptomatic cardiotoxicity. The long-term significance of these events, isolating known cardiotoxic effects of anthracyclines from those of trastuzumab, and the appropriateness of referring to trastuzumab-related cardiotoxicity as ...
Melinda L, Telli, Ronald M, Witteles
openaire   +2 more sources

Subclinical Cardiac Dysfunction in Sarcoidosis

Chest, 1991
Clinically apparent myocardial disease is infrequent in sarcoidosis. However, autopsy data show myocardial involvement in up to 30 percent of patients. Unexplained exertional symptomatology is a common complaint in patients with sarcoidosis. In this study, we investigated whether abnormal cardiac function might limit exercise performance in patients ...
W J, Gibbons   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy